Please provide your email address to receive an email when new articles are posted on . Cardiologists should consider a woman’s menopause status when assessing their CV risk, according to a ...

Please provide your email address to receive an email when new articles are posted on . Levothyroxine lowered the risk for myocardial infarction and CV-related death for adults with subclinical ...

Investigators sought to evaluate changes in the estimated CV risk of men with prostate cancer after 6 months of hormone therapy using clinical tools established for the general population.

Individuals receiving hormone therapy during gender transition have an increased incidence of acute cardiovascular events, including myocardial infarction (MI), stroke, and venous thromboembolic ...

Among men with testosterone deficiency, users vs nonusers of testosterone therapy did not show differences in cardiovascular safety outcomes. In real-world clinical practice, long-term testosterone ...

Hormone therapy taken as part of the transitioning process appears to increase the risk of cardiovascular events for both trans women, who were assigned male sex at birth but have a female gender ...

Barcelona, Spain – Sunday 31 August 2014: Antihypertensive therapy reduces the risk of cardiovascular (CV) events, strokes and mortality in hypertensive older adults, according to research presented ...